What a degenerative meniscus tear actually is

A scan report showing a 'torn meniscus' can feel alarming — but for many adults over 40, the finding reflects something quite different from the knee injuries seen in sport. Understanding that difference is the most important first step.

The meniscus is a crescent-shaped pad of fibrocartilage — two of them, in fact, one on the inner (medial) side of the knee and one on the outer (lateral) side. Together they act as shock absorbers and load distributors between the femur above and the tibia below, and they play a role in joint stability. A degenerative tear is not a structural failure caused by a single force; it is the result of cumulative, age-related wear in tissue that has gradually thinned and lost resilience. Many patients cannot identify a specific injury moment — the pain may have crept on over weeks, or been triggered by something as unremarkable as standing up from a low chair. The medial meniscus is the most commonly affected.

This pattern stands in sharp contrast to the acute traumatic tear seen in a younger athlete who twists suddenly on a planted foot. That injury involves largely healthy tissue subjected to an exceptional force; the biology, the imaging appearance, and the evidence base for management are all different. Applying the logic of a sports injury to a degenerative tear — including the assumption that 'torn' means 'must be fixed surgically' — is one of the most common sources of patient confusion.

Degenerative tears also rarely occur in isolation. They frequently co-exist with early knee osteoarthritis as part of the same ageing process in the joint, rather than as two separate problems that happen to coincide.

Where the tear sits within the meniscus matters biologically. The outer third — the red zone — has a blood supply and retains some capacity for natural recovery. Tears deeper in the avascular inner zone have minimal regenerative potential, but many remain mechanically stable and produce no significant functional impairment. The presence of a tear on an MRI is not, by itself, a verdict about pain or prognosis.

Why your MRI may not be the cause of your pain

Receiving a radiology report that lists meniscal fraying, signal change, or a horizontal tear can make the knee feel suddenly fragile — yet the report alone tells you less than it might appear to.

Degenerative changes in the meniscus are remarkably common in adults over 40. Studies consistently find such changes on MRI in people who have no pain, no swelling, and no limitation in their daily activities. The same imaging appearance that prompts concern in one person may be entirely incidental in another. This is what clinicians call the scan-pain mismatch: structural findings and symptoms frequently do not track together.

Part of the reason is that the tear itself is not always the dominant source of pain. Perimeniscal synovitis — inflammation of the joint lining that releases mediators including IL-1β and IL-6 — can be an independent and substantial pain driver, and it responds to the kinds of targeted conservative treatment that an MRI cannot predict will or will not work.

This matters practically. A consultant uses the MRI as one piece of evidence alongside a thorough history, a clinical examination, and an assessment of how the knee actually functions day to day. Signal change or fraying on an image does not, on its own, indicate that the knee is deteriorating or that surgery is required to prevent future harm. Many patients with identical scan findings follow entirely different symptom trajectories depending on their activity levels, muscle support, weight, and inflammatory load.

The guiding principle is that symptoms and function — not imaging alone — should direct management decisions.

The evidence against routine surgery for degenerative tears

The shift in clinical thinking on this question rests on some of the most rigorously designed trials in orthopaedic surgery — and the findings point in a consistent direction.

The landmark evidence comes from the FIDELITY trial, a Finnish randomised controlled trial that compared arthroscopic partial meniscectomy (APM) directly against sham surgery in 146 adults aged 35–65 with symptomatic degenerative meniscal tears. Sham surgery is a deliberately stringent control: patients underwent identical anaesthesia and skin incisions without any tissue being removed. At two-year follow-up, WOMET score, Lysholm score, and pain after exercise showed no significant differences between the two groups. The sham group did as well as the group who had the real procedure.

The five-year FIDELITY data, published in 2020, extended that finding and added a caution. Patient-reported outcomes remained equivalent, but the APM group showed an adjusted absolute risk difference of 13% for radiographic OA progression (Kellgren-Lawrence grade ≥1) compared with the sham group, alongside an 18% higher rate of post-operative mechanical symptoms. Surgery did not merely fail to demonstrate benefit — it was associated with measurable harms the sham arm avoided.

This is not a single outlier. A 2026 systematic review of 45 publications — 34 RCTs and 11 meta-analyses — found that 91.3% reported no significant clinical outcome advantage for APM over conservative therapy beyond 12 months; any short-term benefit lasted only 6–12 months. The Noorduyn 2022 study, published in JAMA Network Open and now cited over 90 times, reached the same conclusion, supporting physical therapy as the preferred first-line treatment. A 2024 economic evaluation of FIDELITY data confirmed APM is not cost-effective compared with sham diagnostic arthroscopy for degenerative medial meniscus tears. Across these sources, up to 80% of patients with symptomatic degenerative tears achieve meaningful relief through rehabilitation alone.

The evidence is strongest for adults aged 35–65 with no or early radiographic OA and no true mechanical locking — and current clinical guidelines now reflect that, discouraging routine arthroscopy in this group in favour of structured conservative management. Surgery has not become contraindicated; it has become a specific rather than a default option.

What conservative treatment involves and what to expect

Conservative management is an active process — structured, graduated, and evidence-based — not a holding pattern while waiting for a decision about surgery.

The foundation is supervised physiotherapy. A tailored programme typically targets quadriceps and hamstring strengthening, hip abductor control, and neuromuscular coordination, all of which reduce compressive load on the knee during everyday movement. The specific exercises are something a treating physiotherapist will individualise; what the evidence supports is the principle that targeted loading, not rest, drives recovery. Most patients notice meaningful symptom improvement within four to six weeks; a full programme generally spans three to six months.

Short-term NSAIDs can help settle acute pain flares enough to allow rehabilitation to progress, but they function as a bridge to movement rather than a standalone strategy, and are not suited to long-term use for this condition.

Where pain significantly limits rehabilitation — particularly when early osteoarthritis is also present — intra-articular injections can serve as an adjunct. Corticosteroid is typically the first choice when acute inflammation is the principal barrier; hyaluronic acid or biologic options such as PRP tend to be considered when the concern is the broader OA joint environment and inflammation-first measures have not fully addressed symptoms. The appropriate option depends on OA stage, symptom pattern, and treatment history, and is determined at specialist assessment.

Weight management deserves particular attention. A 48-month study of 189 patients with degenerative meniscal tears identified BMI as the dominant modifiable factor for OA progression — making it as clinically relevant as the rehabilitation programme itself. Low-impact activity such as swimming or cycling supports both weight control and progressive joint loading without aggravating the knee.

When surgery is genuinely the right option

None of the preceding evidence makes surgery categorically inappropriate — it makes it specific. Several clinical presentations genuinely warrant surgical referral, and recognising them matters as much as avoiding unnecessary intervention.

True mechanical locking is the clearest threshold. This is not stiffness on waking or aching at end-range — it is the inability to fully extend the knee, suggesting a displaced bucket-handle fragment is physically blocking normal joint mechanics. This presentation typically does not resolve with physiotherapy, and a prolonged conservative trial is unlikely to help.

Persistent joint instability unresponsive to conservative management is a second indication. Where the knee gives way unpredictably despite a structured rehabilitation programme, specialist assessment is warranted to determine whether a mechanical rather than purely symptomatic problem underlies the presentation.

Failure of comprehensive conservative care — defined in current guidelines as documented adherence to a supervised programme over three to six months without adequate improvement — is the accepted escalation point. The emphasis on 'documented adherence' is significant: the trials comparing surgery with conservative management assume a genuine and consistent rehabilitation effort, not a brief or unsupported attempt.

When surgery does become the right path, the choice of procedure carries long-term consequences. A meta-analysis of over 31,000 patients found meniscal repair associated with an OA progression rate of approximately 21%, compared with 51% for meniscectomy, alongside a lower rate of progression to total knee replacement. Where anatomically feasible, preserving meniscal tissue is therefore the preferred surgical principle rather than simple removal — a point that influences which procedure a surgeon should aim for, not just whether to operate.

Some groups sit outside the clearest evidence: patients with severe pre-existing osteoarthritis, younger patients with more structurally intact cartilage, and those with high BMI each face a different risk-benefit profile that the main RCT populations may not fully represent. For these patients, a blanket pathway does not apply — individualised specialist assessment is the appropriate starting point.

Why the right assessment comes before any treatment decision

Getting to the right management pathway depends on more than an MRI report. A scan identifies structural change; it cannot establish whether that change is mechanically significant, whether perimeniscal synovitis is the dominant pain driver, or whether an altered loading pattern is placing disproportionate stress on the affected compartment. Treating a degenerative signal change as the sole explanation — when inflammatory pain or biomechanical compensation is doing most of the work — risks pursuing the wrong intervention entirely: surgery for a problem that is primarily inflammatory, or rehabilitation prescribed without accounting for a true mechanical block.

A thorough assessment combines symptom history, physical examination, and imaging into a single clinical picture. Objective gait and load analysis — such as MAI Motion® assessment — can add biomechanical context that a static scan cannot provide, while AI-assisted MRI interpretation (onMRI™) helps characterise meniscal tissue condition in ways that inform treatment planning as well as diagnosis.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral; book an assessment at lincolnshireknee.co.uk. For the majority of adults with degenerative meniscal tears, the evidence supports starting with conservative care — and accurate early assessment is what establishes which pathway applies and whether it is working.

1. [1] Evaluation of radiographic knee OA progression after arthroscopic meniscectomy compared with IACI for degenerative meniscus tear. (2025). https://doi.org/10.1038/s41598-025-95649-9 https://doi.org/10.1038/s41598-025-95649-9
2. [2] Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5-year follow-up of the placebo-surgery controlled FIDELITY trial. (2020). https://doi.org/10.1136/bjsports-2020-102813 https://doi.org/10.1136/bjsports-2020-102813
3. [3] Meniscectomy is associated with a higher rate of osteoarthritis compared to meniscal repair following acute tears: a meta-analysis. (2023). https://doi.org/10.1007/s00167-023-07600-y https://doi.org/10.1007/s00167-023-07600-y
4. [4] Osteoarthritis Development Following Meniscectomy vs. Meniscal Repair for Posterior Medial Meniscus Injuries: A Systematic Review. (2024). https://doi.org/10.3390/medicina60040569 https://doi.org/10.3390/medicina60040569
5. [5] Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery (FIDELITY trial economic evaluation). (2024). https://doi.org/10.1097/CORR.0000000000003094 https://doi.org/10.1097/CORR.0000000000003094